
News|Podcasts|June 2, 2010
Podcast: Powder Dynamics and QbD
Advertisement
b
Tim Freeman on Powder Dynamics and QbD
The QbD initiative is driving pharmaceutical chemists, formulators, process developers, and manufacturers to come to a better, more detailed understanding of the characteristics of the ingredients they’re working with and how those ingredients behave during different phases of the manufacturing process. Many of these ingredients are powdered solids, and scientists are trying to learn what they can about the characteristics of their constituent particles. This is no easy task.
Editor-in-Chief Michelle Hoffman talks to Tim Freeman, Director of Operations at Freeman Technology, about the industry’s current level of understanding about powder characteristics and dynamics.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
2
Technology Transfer: Success Drivers and Obstacles Explained
3
Managing Global Trial Supply Risk: Expert Insights
4
How to Vet Importer of Record Partners for Clinical Trials
5



